AT356263B - METHOD FOR PRODUCING AN ANTIGENT FOR USE IN IMMUNOLOGICAL CONTROL OF REPRODUCTION - Google Patents

METHOD FOR PRODUCING AN ANTIGENT FOR USE IN IMMUNOLOGICAL CONTROL OF REPRODUCTION

Info

Publication number
AT356263B
AT356263B AT377074A AT377074A AT356263B AT 356263 B AT356263 B AT 356263B AT 377074 A AT377074 A AT 377074A AT 377074 A AT377074 A AT 377074A AT 356263 B AT356263 B AT 356263B
Authority
AT
Austria
Prior art keywords
antigent
reproduction
producing
immunological control
immunological
Prior art date
Application number
AT377074A
Other languages
German (de)
Other versions
ATA377074A (en
Original Assignee
Univ Ohio State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State filed Critical Univ Ohio State
Publication of ATA377074A publication Critical patent/ATA377074A/en
Application granted granted Critical
Publication of AT356263B publication Critical patent/AT356263B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT377074A 1973-05-07 1974-05-07 METHOD FOR PRODUCING AN ANTIGENT FOR USE IN IMMUNOLOGICAL CONTROL OF REPRODUCTION AT356263B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35789273A 1973-05-07 1973-05-07
US40682173A 1973-10-16 1973-10-16

Publications (2)

Publication Number Publication Date
ATA377074A ATA377074A (en) 1979-09-15
AT356263B true AT356263B (en) 1980-04-25

Family

ID=26999834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT377074A AT356263B (en) 1973-05-07 1974-05-07 METHOD FOR PRODUCING AN ANTIGENT FOR USE IN IMMUNOLOGICAL CONTROL OF REPRODUCTION

Country Status (17)

Country Link
JP (1) JPS623128B2 (en)
AT (1) AT356263B (en)
AU (1) AU524925B2 (en)
CA (1) CA1057742A (en)
CH (1) CH622426A5 (en)
DD (1) DD113919A5 (en)
DE (1) DE2421943A1 (en)
FR (1) FR2228477B1 (en)
GB (1) GB1473601A (en)
HK (1) HK41280A (en)
IE (1) IE42002B1 (en)
IL (1) IL44779A (en)
MY (1) MY8100128A (en)
NL (1) NL7406098A (en)
NZ (1) NZ174192A (en)
PL (1) PL97318B1 (en)
SE (1) SE7406096L (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
CA1054937A (en) * 1975-01-28 1979-05-22 Gursaran P. Talwar Antipregnancy vaccine
FR2319379A1 (en) * 1975-07-29 1977-02-25 All India Inst Medical Scie Contraceptive vaccine for women - comprising a conjugate of tetanus anatoxin andhuman chlorionic gonadotrophin (3-sub-unit with no strong reaction with anti-LH serium)
JPS55160725A (en) * 1975-07-30 1980-12-13 Paashiyado Taruwaa Gaasaran Contraceptive vaccine and its manufacture
NZ182272A (en) * 1975-10-14 1985-03-20 Univ Ohio State Modified polypeptides for the immunological control of fertility,and pharmaceutical compositions
JPS5294416A (en) * 1976-01-24 1977-08-09 Paashiyado Taruwaa Gaasaran Vaccine for contraception and use of same
JPS5633907Y2 (en) * 1976-09-16 1981-08-11
US4096237A (en) * 1977-03-14 1978-06-20 Hoffmann-La Roche Inc. Immunoassay for β-endorphin
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
FR2832066A1 (en) * 2001-11-14 2003-05-16 Agronomique Inst Nat Rech CONTRACEPTIVE VACCINE COMPOSITIONS COMPRISING A PEPTIDE OR A SET OF PEPTIDES ENCODED BY ALL OR PART OF EXON 1 OF AN FSH RECEPTOR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903671A (en) * 1972-06-27 J. Lewis Andrew Soluble cancer antigens coupled to foreign proteins
DE1467782A1 (en) * 1963-07-17 1968-12-12 Behringwerke Ag Process for the production of artificial antigens
US3317400A (en) * 1964-11-23 1967-05-02 Upjohn Co Enzymatic modification of bovine growth hormone by proteolytic streptomycete cell extracts
GB1393965A (en) * 1971-05-05 1975-05-14 Ortho Pharma Corp Vaccine and method for inducing infertility in a male animal

Also Published As

Publication number Publication date
DD113919A5 (en) 1975-07-05
ATA377074A (en) 1979-09-15
CH622426A5 (en) 1981-04-15
GB1473601A (en) 1977-05-18
JPS5069221A (en) 1975-06-10
IL44779A (en) 1977-10-31
SE7406096L (en) 1975-01-31
FR2228477B1 (en) 1977-07-01
DE2421943C2 (en) 1989-10-26
IL44779A0 (en) 1974-07-31
HK41280A (en) 1980-08-15
AU6869574A (en) 1975-11-13
CA1057742A (en) 1979-07-03
DE2421943A1 (en) 1974-11-28
IE42002L (en) 1974-11-07
MY8100128A (en) 1981-12-31
NL7406098A (en) 1974-11-11
AU524925B2 (en) 1982-10-14
NZ174192A (en) 1985-02-28
JPS623128B2 (en) 1987-01-23
FR2228477A1 (en) 1974-12-06
IE42002B1 (en) 1980-05-21
PL97318B1 (en) 1978-02-28

Similar Documents

Publication Publication Date Title
AT356263B (en) METHOD FOR PRODUCING AN ANTIGENT FOR USE IN IMMUNOLOGICAL CONTROL OF REPRODUCTION
AT346201B (en) METHOD FOR PRODUCING ABRASIVE BODIES
AT335995B (en) METHOD FOR PRODUCING KETOISOPHORONE
AT370714B (en) METHOD FOR PRODUCING ALDEHYDES
AT343295B (en) METHOD FOR PRODUCING NEW HAPTENSTEROIDS
AT341083B (en) METHOD FOR PRODUCING NEW RIFAMYCINE
AT362497B (en) METHOD FOR PRODUCING TUMOR ANTIGENS
AT338232B (en) METHOD FOR PRODUCING KETOISOPHORONE
AT341118B (en) METHOD FOR PRODUCING NEW DOTRACONTAPEPTIDAMIDE
AT340901B (en) METHOD FOR PRODUCING NEW SUBSTITUTED BENZOPHENONE
AT342015B (en) METHOD FOR PRODUCING ACETOACETAMIDE-N-SULFOFLUORIDE
AT336634B (en) METHOD FOR PRODUCING POLY-N-ALKYLIMINOALANES
AT351768B (en) PROCESS FOR PRODUCING AN ANTI-STRUCTURAL MEDIUM MIXTURE
AT343629B (en) METHOD FOR PRODUCING 2-ARYLPROPIONALDEHYDE
DD130933A5 (en) METHOD FOR PRODUCING SULFINYLAZETIDINONES
ATA895774A (en) METHOD FOR PRODUCING FLOWED RIOLITE GLASSES
AT344666B (en) METHOD FOR PRODUCING AN OXYCHLORATION CATALYST
AT356055B (en) METHOD FOR PRODUCING A WIFELESS TAPE
AT344329B (en) METHOD FOR PRODUCING ANTIGENS
AT346275B (en) METHOD FOR PRODUCING BRIKETTS
ATA652574A (en) METHOD FOR PRODUCING 6-METHYL-5-HEPTEN-2-ON METHOD FOR PRODUCING 6-METHYL-5-HEPTEN-2-ON
AT340885B (en) METHOD FOR PRODUCING ACETOACETAMIDE-N-SULFOFLUORIDE
AT387375B (en) CONTINUOUS METHOD FOR PRODUCING CHLORDIOXIDE
DD129268A3 (en) METHOD FOR PRODUCING HIGH-STYLE-CONTAINING LATICES
DD135911A1 (en) METHOD FOR PRODUCING TUMOR ANTIGEN

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee